Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.05 USD | +2.52% | +5.34% | +1.96% |
05-08 | Stifel Cuts Price Target on Astrana Health to $45 From $50, Maintains Buy Rating | MT |
05-07 | Transcript : Astrana Health, Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.96% | 1.81B | |
+18.92% | 81.04B | |
-29.48% | 68.93B | |
+9.65% | 29.59B | |
-0.14% | 17.24B | |
-9.30% | 16.99B | |
+0.20% | 15.12B | |
+5.25% | 13.09B | |
+68.96% | 12B | |
-2.88% | 11.94B |
- Stock Market
- Equities
- ASTH Stock
- News Astrana Health, Inc.
- Truist Initiates Apollo Medical With Hold Rating, Price Target is $41